MBGPF
MOBERG PHARMA AB by MOBERG PHARMA AB (MBGPF)
$91
About MOBERG PHARMA AB by MOBERG PHARMA AB (MBGPF)
Moberg Pharma AB is a pharmaceutical company, which engages in the development and commercialization of medical products. Its product pipeline includes MOB-015, which is a treatment for nail fungus. The company was founded by Peter Gunnar Maurits Wolpert and Marie Moberg in March 2006 and is headquartered in Bromma, Sweden.
Details
Daily high
$0.91
Daily low
$0.91
Price at open
$0.91
52 Week High
$1.47
52 Week Low
$0.69
Market cap
43.6M
Dividend yield
0.00%
Volume
1,279
Avg. volume
947
P/E ratio
-1.80
MOBERG PHARMA AB by MOBERG PHARMA AB News
Details
Daily high
$0.91
Daily low
$0.91
Price at open
$0.91
52 Week High
$1.47
52 Week Low
$0.69
Market cap
43.6M
Dividend yield
0.00%
Volume
1,279
Avg. volume
947
P/E ratio
-1.80